Cordant Inc’s Amdocs DOX Stock Holding History

Cordant Inc’s Portfolio DOX Stock Details DOX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-42	Closed	-$3K	–	395
2022 Q1	$3K	Buy	+42	New	+$3.29K	﹤0.01%	458

Other funds holding DOX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

BGC

Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Cordant Inc's DOX Position: Q2 2022 in Review

Cordant Inc sold out of Amdocs (DOX) in Q2 2022, closing a stake of 42 shares — an estimated $3K sold.

Cordant Inc first reported a position in DOX in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 450 funds tracked by Wall St. Rank hold DOX as of Q2 2022.

Cordant Inc reported no remaining Amdocs position as of Q2 2022 after selling out during the quarter.
Cordant Inc sold 42 Amdocs shares in Q2 2022, an estimated $3K.
Cordant Inc first reported a position in Amdocs in Q1 2022 and held it in 1 quarter.
Cordant Inc's Amdocs position peaked at $3K in Q1 2022.
450 funds tracked by Wall St. Rank held Amdocs as of Q2 2022.

Based on Cordant Inc's 13F filing for Q2 2022, filed 17 Aug 2022.